Detalhe da pesquisa
1.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28578639
2.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Lancet
; 387(10024): 1163-77, 2016 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719232
3.
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols.
Clin Trials
; 14(5): 451-461, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28830236
4.
Abiraterone in Metastatic Prostate Cancer.
N Engl J Med
; 377(17): 1696-7, 2017 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29069563
5.
Could a brief assessment of negative emotions and self-esteem identify adolescents at current and future risk of self-harm in the community? A prospective cohort analysis.
BMC Public Health
; 13: 604, 2013 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23800153
6.
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.
Eur J Cancer
; 84: 88-101, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28800492
7.
Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.
J Clin Oncol
; 35(14): 1530-1541, 2017 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28300506
8.
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial.
JAMA Oncol
; 2(3): 348-57, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26606329
9.
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).
Eur Urol
; 67(6): 1028-1038, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25301760
10.
Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial.
Eur Urol
; 66(5): 799-802, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24985962